SCHEMBL5550440

SCHEMBL5550440

CC1(C)CC(C(=O)O)NC1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.55
KMT2A Q03164 2/20 0.39
APLNR P35414 1/20 0.37
CYP2D6 P10635 2/20 0.36
LMNA P02545 2/20 0.36
BLM P54132 2/20 0.36
ALOX15 P16050 2/20 0.36
CYP1A2 P05177 2/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
MEN1 O00255 1/20 0.36
THRB P10828 1/20 0.36
PMP22 Q01453 1/20 0.36
CAD P27708 2/20 0.34
GRM2 Q14416 1/20 0.33
GRM3 Q14832 1/20 0.33
IKBKB O14920 1/20 0.33
EGLN1 Q9GZT9 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1973599 1.00 HTT (0.55) HTTKMT2AAPLNRCYP2D6LMNA
SCHEMBL18576561 0.82 HTT (0.53) HTTKMT2AAPLNRCYP2D6LMNA
SCHEMBL10137633 0.79 KMT2A (0.58) HTTKMT2ACYP2D6ALOX15CYP1A2
SCHEMBL25414098 0.75 HTT (0.46) HTTKMT2ACYP2D6LMNABLM
SCHEMBL19585894 0.75 HTT (0.46) HTTKMT2ACYP2D6LMNABLM
SCHEMBL25414095 0.75 HTT (0.46) HTTKMT2ACYP2D6LMNABLM
SCHEMBL7551520 0.75 HTT (0.46) HTTKMT2ACYP2D6LMNABLM
SCHEMBL7455295 0.75 HTT (0.46) HTTKMT2ACYP2D6LMNABLM
Limazocic SCHEMBL9329801 0.74 HTT (0.58) HTTKMT2ACADMAPTITGA4
Limazocic SCHEMBL9326335 0.74 HTT (0.58) HTTKMT2ACADMAPTITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017189866-A1 POLYMYXIN ANALOGS USEFUL AS ANTIBIOTIC POTENTIATORS SPERO OPCO (US) 2017-11-02 WO disclosed
EP-1481000-B1 NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS SCHERING CORP (US) 2010-06-02 EP disclosed
EP-1385870-B1 PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS SCHERING CORP (US) 2010-03-17 EP disclosed
EP-1593682-B1 Derivatives of 4-oxo-4,6,7,8-tetrahydropyrrolo¬1,2-a pyrazine-6-carboxamides, process for their preparation and pharmaceutical compositions thereof SERVIER LAB (FR) 2007-11-07 EP disclosed
EP-1593682-A2 Derivatives of 4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides, process for their preparation and pharmaceutical compositions thereof LES LABORATOIRES SERVIER (FR) 2005-11-09 EP disclosed